Kidney Stone Research Company and Calcium Oxalate Labs, Inc., the makers of Kidney C.O.P.® Calcium Oxalate Protector, have been awarded its 5th patent from the U.S. Patent Office. This level of patent awards for a kidney health supplement in the United States is unparalleled and signifies the tremendous innovation and scientific research behind Kidney C.O.P.®.
® is also manufactured in a FDA cGMP compliant facility.
GMP stands for Good Manufacturing Practice and the “C” in cGMP stands for current.
As a whole, this means that the manufacturing process utilized to manufacture Kidney C.O.P.
® follows up to date current Good Manufacturing Practice regulations set by the FDA.
If you’re one of many people that need the extra help from Kidney C.O.P.
® to deal with calcium oxalate crystals, then you’ve probably seen some great results.
The current exploratory writing seeks to examine the clinical presentation of chronic kidney disease, diagnosis, the role of patient history, physical exams, and diagnostics, implications of potential treatment options, including prescribed drugs, and the impact of patient factors on diagnosis and treatment.Early clinical and laboratory signs of renal disease often have a vague representation and do not cause medical vigilance, particularly, in old patients.
Moreover, physicians deeply examine pathologic processes caused by the primary disease entity, including diabetes and hypertension, as well as seek to identify effects of progressive renal failure.
It occurs in all progressive kidney diseases accompanied by the disturbances of water-electrolyte and acid-base balances.
At the early stage, the most fundamental function of kidneys, the ability to allocate water adequately, violates because of the inability to concentrate urine and the approximation of urine osmolality to the blood plasma one.
Family’s health problems and changes in urinary habits are also taken into account.
Moreover, physicians also encourage passing specific tests and procedures, including imaging, urine, and blood ones.
